Due to maintenance work, this service will be unavailable from
Mon Nov 11 17:30 until
Tue Nov 12 09:00
CET.
Apologies for the inconvenience.
HAMAP rule MF_01480
General rule information
[?]
Accession | MF_01480 |
Dates | 17-JAN-2013 (Created)
1-JUN-2023 (Last updated, Version 11) |
Name | Cas9 |
Scope(s) |
Bacteria |
Template(s) | Q99ZW2 (CAS9_STRP1); G3ECR1 (CAS9_STRTR); Q03JI6 (CAS9B_STRTD); Q927P4 (CAS9_LISIN); J7RUA5 (CAS9_STAAU); A0Q5Y3 (CAS9_FRATN); [ Recover all ] |
Triggered by |
HAMAP; MF_01480 (Get profile general information and statistics) |
Propagated annotation
[?]
Identifier, protein and gene names
[?]
Identifier | CAS9 |
Protein name | RecName: Full=CRISPR-associated endonuclease Cas9; EC=3.1.-.-; |
Gene name | Name=cas9; |
Comments
[?]
FUNCTION | CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 (rnc) and this protein. The tracrRNA serves as a guide for ribonuclease 3-aided processing of pre-crRNA. Subsequently Cas9/crRNA/tracrRNA endonucleolytically cleaves linear or circular dsDNA target complementary to the spacer; Cas9 is inactive in the absence of the 2 guide RNAs (gRNA). Cas9 recognizes the protospacer adjacent motif (PAM) in the CRISPR repeat sequences to help distinguish self versus nonself, as targets within the bacterial CRISPR locus do not have PAMs. PAM recognition is also required for catalytic activity. |
case <FTGroup:1> or <FTGroup:2> | |
COFACTOR | Name=Mg(2+); Xref=ChEBI:CHEBI:18420; |
end case | |
SUBUNIT | Monomer. Binds crRNA and tracrRNA. |
DOMAIN | Has 2 endonuclease domains. The discontinuous RuvC-like domain cleaves the target DNA noncomplementary to crRNA while the HNH nuclease domain cleaves the target DNA complementary to crRNA. |
SIMILARITY | Belongs to the CRISPR-associated Cas9 family. |
Keywords
[?]
Antiviral defense | |
DNA-binding | |
Endonuclease | |
Hydrolase | |
case <FTGroup:1> or <FTGroup:2> | |
Magnesium | |
Metal-binding | |
end case | |
Nuclease | |
RNA-binding |
Gene Ontology
[?]
GO:0004519; Molecular function:endonuclease activity |
GO:0046872; Molecular function:metal ion binding |
GO:0051607; Biological process:defense response to virus |
GO:0043571; Biological process:maintenance of CRISPR repeat elements |
Cross-references
[?]
Features
[?]
From: CAS9_STRP1 (Q99ZW2) | ||||||||||||
Key | From | To | Description | Tag | Condition | FTGroup | ||||||
ACT_SITE | 10 | 10 | /note="For RuvC-like nuclease domain" | D | ||||||||
ACT_SITE | 840 | 840 | /note="Proton acceptor for HNH nuclease domain" | H | ||||||||
BINDING | 10 | 10 | /ligand="Mg(2+)" /ligand_id="ChEBI:CHEBI:18420" /ligand_label="1" |
D | 1 | |||||||
BINDING | 10 | 10 | /ligand="Mg(2+)" /ligand_id="ChEBI:CHEBI:18420" /ligand_label="2" |
D | 2 | |||||||
BINDING | 762 | 762 | /ligand="Mg(2+)" /ligand_id="ChEBI:CHEBI:18420" /ligand_label="1" |
E | 1 | |||||||
BINDING | 766 | 766 | /ligand="Mg(2+)" /ligand_id="ChEBI:CHEBI:18420" /ligand_label="1" |
E | 1 | |||||||
BINDING | 766 | 766 | /ligand="Mg(2+)" /ligand_id="ChEBI:CHEBI:18420" /ligand_label="2" |
E | 2 | |||||||
BINDING | 983 | 983 | /ligand="Mg(2+)" /ligand_id="ChEBI:CHEBI:18420" /ligand_label="2" |
H | 2 |
Additional information
[?]
Size range | 984-1688 amino acids |
Related rules |
None |
Fusion | Nter: None Cter: None |
Comments | The signature gene for type II CRISPR/Cas systems. The simplicity of the system (1 protein plus 2 gRNAs that can be engineered into 1 longer transcript) has been used for genome editing in human, mouse, plant, yeast and bacterial cells. Introduction of multiple sgRNAs leads to multiplexed editing of genomic loci; DNA has also been inserted into mammals. |